BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9212232)

  • 1. Immunoreactivities of polyclonal and monoclonal anti-T and anti-Tn antibodies with human carcinoma cells, grown in vitro and in a xenograft model.
    Avichezer D; Springer GF; Schechter B; Arnon R
    Int J Cancer; 1997 Jul; 72(1):119-27. PubMed ID: 9212232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tn, a carcinoma-associated antigen, reacts with anti-Tn of normal human sera.
    Springer GF; Taylor CR; Howard DR; Tegtmeyer H; Desai PR; Murthy SM; Felder B; Scanlon EF
    Cancer; 1985 Feb; 55(3):561-9. PubMed ID: 2981150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity analysis of murine monoclonal antibodies reactive with Tn, sialylated Tn, T, and monosialylated (2-->6) T antigens.
    O'Boyle KP; Markowitz AL; Khorshidi M; Lalezari P; Longenecker BM; Lloyd KO; Welt S; Wright KE
    Hybridoma; 1996 Dec; 15(6):401-8. PubMed ID: 8985750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer.
    Mazal D; Lo-Man R; Bay S; Pritsch O; Dériaud E; Ganneau C; Medeiros A; Ubillos L; Obal G; Berois N; Bollati-Fogolin M; Leclerc C; Osinaga E
    Cancer Immunol Immunother; 2013 Jun; 62(6):1107-22. PubMed ID: 23604173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of bispecific monoclonal antibody (bsAb)-targeted cytolysis by human anti-mouse antibodies in ovarian carcinoma patients treated with bsAb-targeted activated T-lymphocytes.
    Lamers CH; Gratama JW; Warnaar SO; Stoter G; Bolhuis RL
    Int J Cancer; 1995 Feb; 60(4):450-7. PubMed ID: 7829257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of human tumor mucin-associated carbohydrate epitopes, including sialylated Tn, and localization of murine monoclonal antibodies CC49 and B72.3 in a syngeneic rat colon carcinoma model.
    O'Boyle KP; Goya V; Zuckier LS; Chun S; Bhargava K
    J Immunother Emphasis Tumor Immunol; 1994 Nov; 16(4):251-61. PubMed ID: 7533599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses of mice and human breast cancer patients following immunization with synthetic sialyl-Tn conjugated to KLH plus detox adjuvant.
    Longenecker BM; Reddish M; Koganty R; MacLean GD
    Ann N Y Acad Sci; 1993 Aug; 690():276-91. PubMed ID: 7690215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium.
    Chang K; Pastan I; Willingham MC
    Int J Cancer; 1992 Feb; 50(3):373-81. PubMed ID: 1735605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.
    Kjeldsen T; Clausen H; Hirohashi S; Ogawa T; Iijima H; Hakomori S
    Cancer Res; 1988 Apr; 48(8):2214-20. PubMed ID: 2450649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.
    Weiner LM; Holmes M; Adams GP; LaCreta F; Watts P; Garcia de Palazzo I
    Cancer Res; 1993 Jan; 53(1):94-100. PubMed ID: 8093231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A short synthetic peptide (DTRPAP) induces anti-mucin (MUC-1) antibody, which is reactive with human ovarian and breast cancer cells.
    Avichezer D; Taylor-Papadimitriou J; Arnon R
    Cancer Biochem Biophys; 1998 Jun; 16(1-2):113-28. PubMed ID: 9923971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro binding characteristics and biodistribution in tumor-bearing athymic mice of anti-ovarian carcinoma monoclonal antibodies.
    Boerman O; Massuger L; Makkink K; Thomas C; Kenemans P; Poels L
    Anticancer Res; 1990; 10(5A):1289-95. PubMed ID: 2241105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
    Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human urinary bladder carcinoma glycoconjugates expressing T-(Gal beta(1-3)GalNAc alpha 1-O-R) and T-like antigens: a comparative study using peanut agglutinin and poly- and monoclonal antibodies.
    Langkilde NC; Wolf H; Clausen H; Orntoft TF
    Cancer Res; 1992 Sep; 52(18):5030-6. PubMed ID: 1516058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse-human chimeric anti-Tn IgG1 induced anti-tumor activity against Jurkat cells in vitro and in vivo.
    Ando H; Matsushita T; Wakitani M; Sato T; Kodama-Nishida S; Shibata K; Shitara K; Ohta S
    Biol Pharm Bull; 2008 Sep; 31(9):1739-44. PubMed ID: 18758069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and distribution in human tissues of a glycoproteic antigen defined by monoclonal antibody 1BE12 raised against the human breast cancer cell line T47D.
    Pancino G; Charpin C; Osinaga E; Betaille B; Le Roy M; Calvo F; Roseto A
    Cancer Res; 1990 Nov; 50(22):7333-42. PubMed ID: 2224861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific role of T and Tn tumor-associated antigens in adhesion between a human breast carcinoma cell line and a normal human breast epithelial cell line.
    Kishikawa T; Ghazizadeh M; Sasaki Y; Springer GF
    Jpn J Cancer Res; 1999 Mar; 90(3):326-32. PubMed ID: 10359048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new murine IgG1 anti-Tn monoclonal antibody with in vivo anti-tumor activity.
    Welinder C; Baldetorp B; Borrebaeck C; Fredlund BM; Jansson B
    Glycobiology; 2011 Aug; 21(8):1097-107. PubMed ID: 21470982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Products of Chemoenzymatic Synthesis Representing MUC1 Tandem Repeat Unit with T-, ST- or STn-antigen Revealed Distinct Specificities of Anti-MUC1 Antibodies.
    Yoshimura Y; Denda-Nagai K; Takahashi Y; Nagashima I; Shimizu H; Kishimoto T; Noji M; Shichino S; Chiba Y; Irimura T
    Sci Rep; 2019 Nov; 9(1):16641. PubMed ID: 31719620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting human T-lymphocytes with bispecific antibodies to react against human ovarian carcinoma cells growing in nu/nu mice.
    Garrido MA; Valdayo MJ; Winkler DF; Titus JA; Hecht TT; Perez P; Segal DM; Wunderlich JR
    Cancer Res; 1990 Jul; 50(14):4227-32. PubMed ID: 2142014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.